FDA Approves Libtayo (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-Small Cell Lung Cancer with PD-L1 Expression of ≥50%

TARRYTOWN, N.Y. and PARIS, Feb. 22, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration

Read more

APO-Amlodipine/Atorvastatin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-Amlodipine/Atorvastatin Tablets 5/10, 5/20, 5/40, 5/80, 10/10,

Read more

Blooms The Chemist Pregabalin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BLOOMS THE CHEMIST PREGABALIN Contains the active

Read more

Midazolam Apotex

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MIDAZOLAM APOTEX SOLUTION FOR INJECTION Midazolam Consumer

Read more

Pegasys

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEGASYS®  180710 pronounced peg-ah-sis contains the active

Read more